{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-23-000017","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2023-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.567519+00:00","generated_at":"2026-06-17T17:25:17.504381+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Integra LifeSciences enters $2.075B credit agreement, extends maturity to 2028","bullets":["New credit facility: $1.3B revolver and $775M term loan, total $2.075B.","Maturity extended from Feb 2025 to Mar 24, 2028, with springing conditions.","Interest at Term SOFR + 1.00%-1.75% or base rate; commitment fee 0.15%-0.30%.","Proceeds used for general corporate purposes, replacing prior 2020 credit agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-23-000017","json":"https://secwatch.observer/filing/0000917520-23-000017.json","markdown":"https://secwatch.observer/filing/0000917520-23-000017.md","text":"https://secwatch.observer/filing/0000917520-23-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/0000917520-23-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/iart-20230324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T17:25:17.504381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"856e0c6abceef28c5d6ecffaf5c0ce745d70bb64","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP incurred credit facility of up to $2.075 billion with Bank of America, N.A., as Administrative Agent at term SOFR plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%) maturing March 24, 2028.","evidence_excerpt":"On March 24, 2023, Integra LifeSciences Holdings Corporation (the “Company”) entered into an amended and restated credit agreement with a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., JPMorgan Chase Bank, N.A., Morgan Stanley MUFG Loan Partners, LLC, PNC Bank, N.A., Truist Securities, Inc. and Wells Fargo Bank, N.A., as Co-Syndication Agents, and The Bank of Nova Scotia, BMO Harris Bank N.A., BNP Paribas, Capital One, National Association, Citizens Bank, N.A., DNB Bank ASA, New York Branch, Santander Bank, N.A. and TD Bank, N.A., as Co-Documentation Agents (the “Amendment and Restatement”). The Amendment and Restatement makes an aggregate principal amount of up to $2.075 billion available to the Company through the following facilities: (i) a $1.3 billion revolving credit facility, and (ii) a $775 million term loan facility, which includes a $60 million sublimit for the issuance of standby letters of credit","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/0000917520-23-000017-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"up to $2.075 billion"},{"label":"Counterparty","value":"Bank of America, N.A., as Administrative Agent"},{"label":"Rate","value":"term SOFR plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%)"},{"label":"Maturity","value":"March 24, 2028"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"36b73bb484023dc344b19f4247a0c35436141fc1","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP amended Amendment and Restatement with Bank of America, N.A., as Administrative Agent, and a syndicate of lending banks valued at $2.075 billion (effective 2023-03-24).","evidence_excerpt":"On March 24, 2023, Integra LifeSciences Holdings Corporation (the “Company”) entered into an amended and restated credit agreement with a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., JPMorgan Chase Bank, N.A., Morgan Stanley MUFG Loan Partners, LLC, PNC Bank, N.A., Truist Securities, Inc. and Wells Fargo Bank, N.A., as Co-Syndication Agents, and The Bank of Nova Scotia, BMO Harris Bank N.A., BNP Paribas, Capital One, National Association, Citizens Bank, N.A., DNB Bank ASA, New York Branch, Santander Bank, N.A. and TD Bank, N.A., as Co-Documentation Agents (the “Amendment and Restatement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/0000917520-23-000017-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Bank of America, N.A., as Administrative Agent, and a syndicate of lending banks"},{"label":"Value","value":"$2.075 billion"},{"label":"Effective","value":"2023-03-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}